In this UCSF Medical Grand Rounds presentation (April 2, 2020), nine UCSF experts provide an update on what we’ve learned about the epidemiology, virology, clinical manifestations, pathophysiology, and treatments for COVID-19 in the last few weeks. They also highlight some of the strategies that UCSF has taken to address COVID, and discuss reasons that San Francisco is having a very different experience than harder hit areas like New York. The session is hosted by UCSF Department of Medicine chair, Bob Wachter.
Part 1, recorded on March 19, 2020, is Here:
Program
Bob Wachter: Introduction
04:42 – Diane Havlir: Updates in Epidemiology
19:50 – Chaz Langelier: Status in Testing
37:14 – Jen Babik: Updates in Clinical Manifestations
50:08 – Annie Luetkemeyer: Updates in Therapies
01:06:18 – Q&A
01:21:37 – Panel Discussion on the UCSF Response, with 5 more UCSF experts: Matt Aldrich (Critical Care), Brad Monash (Hospital Medicine), Sarah Doernberg (ID and Infection Prevention), George Rutherford (Epidemiology & Biostatistics) and Sirisha Narayana (Hospital Medicine and Ethics)
01:57:15 – Bob Wachter: Closing
